22.10.2020 Geratherm Medical AG  DE0005495626

DGAP-Adhoc: Geratherm Medical AG: Appointment of the Board of Directors


DGAP-Ad-hoc: Geratherm Medical AG / Key word(s): Personnel
Geratherm Medical AG: Appointment of the Board of Directors

22-Oct-2020 / 10:24 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Publication of an insider information pursuant to article 17 of MAR
transmitted by DGAP - a service of EQS Group AG

Appointment of the Board of Directors

Geratal, 22. October 2020 - The Supervisory Board of Geratherm Medical AG has appointed Mr. Christian Frick (49) to the Management Board, effective from January 1, 2021.

Mr. Frick will head the operative business of Geratherm Group and focus on opportunities for medical technology in Asian markets. It is planned that Mr. Frick will assume overall responsibility for the Geratherm Group at the end of the scheduled Annual General Meeting 2021.

After studying business administration in Tübingen, Mr. Frick held various senior management positions at PWC, Voith Group, Capgemini Deutschland GmbH, Süddeutsche Beteiligung GmbH and centrotherm international AG.

For SGL Carbon SE, Mr. Frick has been working in strategic corporate development since 2012, before he headed the China activities in Shanghai as CEO and CFO from 2014 to 2015.

Most recently, Mr. Frick headed international trade business of German branded premium products in online and offline business as well as M&A activities of Chinese BetterLife Group, Beijing.

Geratherm Medical AG
Firmensitz: Fahrenheitstraße 1, 99331 Geratal
Registergericht: Amtsgericht Jena, HRB 111272
Vorstand: Dr. Gert Frank
Aufsichtsratsvorsitzender: Dipl.-Kfm. Rudolf Bröcker
Tel. 036205/98 0
E-Mail: [email protected]

Short company profil:
Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MR Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.



Dr. Gert Frank

22-Oct-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
99331 Geratal
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: [email protected]
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1142458

End of Announcement DGAP News Service

1142458  22-Oct-2020 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022
Umsatzerlöse1 21,41 21,03 21,52 19,85 27,47 23,94 25,85
EBITDA1,2 3,71 1,77 2,80 2,35 4,35 2,31 3,55
EBITDA-Marge3 17,33 8,42 13,01 11,84 15,84 9,65 13,73
EBIT1,4 2,54 0,63 1,99 1,05 3,04 0,59 2,07
EBIT-Marge5 11,86 3,00 9,25 5,29 11,07 2,46 8,01
Jahresüberschuss1 2,25 0,22 0,83 0,29 1,90 0,33 1,08
Netto-Marge6 10,51 1,05 3,86 1,46 6,92 1,38 4,18
Cashflow1,7 0,79 2,47 1,35 1,54 3,92 0,92 2,79
Ergebnis je Aktie8 0,45 0,14 0,23 0,11 0,41 0,02 0,19
Dividende8 0,50 0,47 0,40 0,25 0,40 0,12 0,15
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

Geratherm Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
549562 5,500 Halten 29,95
KGV 2024e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
16,67 26,86 0,71 23,51
1,40 10,75 1,16 7,99
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
0,15 0,15 2,73 28.08.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
- 25.08.2023 - 29.06.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-6,84% -19,79% 10,22% -4,51%
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Geratherm Medical AG  ISIN: DE0005495626 können Sie bei EQS abrufen

Medtech , 549562 , GME , XETR:GME